4,4-dicarboxy-5-pyridoxylproline has been researched along with quipazine in 1 studies
| Studies (4,4-dicarboxy-5-pyridoxylproline) | Trials (4,4-dicarboxy-5-pyridoxylproline) | Recent Studies (post-2010) (4,4-dicarboxy-5-pyridoxylproline) | Studies (quipazine) | Trials (quipazine) | Recent Studies (post-2010) (quipazine) |
|---|---|---|---|---|---|
| 9 | 0 | 4 | 658 | 0 | 41 |
| Protein | Taxonomy | 4,4-dicarboxy-5-pyridoxylproline (IC50) | quipazine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 3E | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 3B | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 1.4454 | |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.47 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 1.4 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 2.7 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0617 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 3.7297 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.0035 | |
| 5-hydroxytryptamine receptor 3A | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 1D | Sus scrofa (pig) | 3.7153 | |
| Adenylate cyclase type 5 | Rattus norvegicus (Norway rat) | 1.4454 | |
| 5-hydroxytryptamine receptor 3D | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 2A | Bos taurus (cattle) | 3.4674 | |
| 5-hydroxytryptamine receptor 3C | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.0035 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, J; Christopher, JA; Congreve, M; Doré, AS; Errey, JC; Koglin, M; Marshall, FH; Myszka, DG; Rich, RL; Tate, CG; Tehan, B; Warne, T | 1 |
1 other study(ies) available for 4,4-dicarboxy-5-pyridoxylproline and quipazine
| Article | Year |
|---|---|
Biophysical fragment screening of the β1-adrenergic receptor: identification of high affinity arylpiperazine leads using structure-based drug design.
Topics: Biophysical Phenomena; Drug Design; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Molecular Docking Simulation; Piperazine; Piperazines; Protein Binding; Protein Conformation; Receptors, Adrenergic, beta-1; Surface Plasmon Resonance | 2013 |